LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global throat pastilles and cough drops market, and the market is poised to grow by USD 1.03 billion during 2020-2024 at a CAGR of almost 4% during the forecast period. Request Free Sample Pages
Read the 152-page research report with TOC on "Throat Pastilles and Cough Drops Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Type (Hard tablet lozenges, Soft tablet lozenges, and Compressed tablet lozenges), and Segment Forecasts, 2020-2024".
The market is driven by the advantages of throat pastilles and cough drops over other dosage forms. Also, the emergence of innovative products is anticipated to further boost the growth of the throat pastilles and cough drops market.
Oral dosage forms are preferred over the parenteral and intravenous route of administrations because they are safer, economical, and easy to administer. Unlike parenteral RoA, it eliminates the need for aseptic techniques required to handle and produce the product. It also eliminates the need for trained personnel for administration. These benefits of oral dosage forms are increasing the preference for throat pastilles and cough drops among patients. Throat pastilles are one of the most widely used solid dosage forms for sore throat and cough relief, which contains drugs or herbal ingredients. Thus, the advantages of throat pastilles and cough drops over other dosage forms is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Throat Pastilles and Cough Drops Market Companies:
GlaxoSmithKline Plc is headquartered in the UK and operates the business under various segments such as Pharmaceuticals, Vaccines, and Consumer Healthcare. The company offers Nicorette and Nicotinell.
iNova Pharmaceuticals is headquartered in Singapore and offers products through the business unit: Pharmaceuticals. The company provides Difflam, which contains the active substance benzydamine hydrochloride.
Johnson & Johnson Services Inc.
Johnson & Johnson Services Inc. is headquartered in the US and operates under various business segments, namely Pharmaceutical, Medical devices, and Consumer. The company offers CODRAL and BENYLIN.
Kestrel Medical Ltd.
Kestrel Medical Ltd. is headquartered in the UK and offers Vocalzone as its vital offering for the throat pastilles and cough drops market.
Pfizer Inc. is headquartered in the US and offers products through the following two business segments: Innovative health and Essential health. The company provides Robitussin, which contains dextromethorphan and is used as a cough suppressant.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Throat Pastilles and Cough Drops Type Outlook (Revenue, USD Million, 2020-2024)
- Hard tablet lozenges
- Soft tablet lozenges
- Compressed tablet lozenges
Throat Pastilles and Cough Drops Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.